Importantly, there is evidence that in active IBD, variant alleles in TLR4 induce dysregulation, and “gain-of-function” mutations exhibit pro-inflammatory effects in response to physiological LPS concentrations. The gene discussed is TLR4; the disease is inflammatory bowel disease.